Schenck et al. [31] have reported that pro-NGF is detected in higher levels in the oral cavity, and it could be used for analgesia in oral mucositis, recurrent oral aphthous ulcers, and radiation-induced osteonecrosis of jaws, which are frequent side effects of OSCC chemotherapy and radiotherapy. This evidence concerns the gene NGF and oral mucositis.